NCT06373016View on ClinicalTrials.gov

Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2027

Conditions
Bipolar DisorderBipolar Disorder Type 1
Interventions
DIETARY_SUPPLEMENT

Glucose

A glucose drink is administered midway through one of the scan sessions.

DIETARY_SUPPLEMENT

Ketones

A ketone drink is administered midway through one of the scan sessions.

Trial Locations (3)

11794

ACTIVE_NOT_RECRUITING

Laufer Center for Physical and Quantitative Biology , Stony Brook University, Stony Brook

02478

RECRUITING

McLean Hospital, Belmont

02129

RECRUITING

Martinos Center for Biomedical Research, Building 149, 13th Street, Charlestown

All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Mclean Hospital

OTHER

lead

Stony Brook University

OTHER